Advances in chemotherapy for pancreatic cancer - Wikidata - wikimedia - TriplyDB

Advances in chemotherapy for pancreatic cancer

Advances in chemotherapy for pancreatic cancer

http://www.wikidata.org/entity/Q28085711

about

EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model.

P2860

Q36734496-14091FB0-ED42-4144-A4FF-F069AEA9650A

P2860

Advances in chemotherapy for pancreatic cancer

http://www.wikidata.org/entity/Q28085711

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Advances in chemotherapy for pancreatic cancer

@ast

Advances in chemotherapy for pancreatic cancer

@en

Advances in chemotherapy for pancreatic cancer

@nl

type

label

Advances in chemotherapy for pancreatic cancer

@ast

Advances in chemotherapy for pancreatic cancer

@en

Advances in chemotherapy for pancreatic cancer

@nl

prefLabel

Advances in chemotherapy for pancreatic cancer

@ast

Advances in chemotherapy for pancreatic cancer

@en

Advances in chemotherapy for pancreatic cancer

@nl

P1433

Q28085711-555FCD85-EE51-4E80-AD3C-D882E1D10F99

P1476

Q28085711-4699D671-7E4A-4138-8A0B-4D33897938B6

P2093

Q28085711-2E59A128-8ABD-4F24-AFC0-796D071D3B84

Q28085711-6D580873-89AF-4C5C-8C7C-D6D694109FC4

Q28085711-E973DC3B-DBD0-43EA-A414-1478D993BF15

Q28085711-EFDA82D1-E1C9-4D4D-826C-FB714C4E4388

P2860

Q28085711-01C101B1-4B49-435B-91EE-CFA8B59A411F

Q28085711-04AECA2F-A8A0-4A24-9241-E56D07912E81

Q28085711-16F4B714-5973-487A-A65E-318D4CB8DEE2

Q28085711-1CD5F4B5-5068-4966-9493-EA927BAC8D89

Q28085711-1EB38A6C-F946-45EB-9378-2301920577AA

Q28085711-23A79B6A-FA39-4221-A2EB-602111BB3DDB

Q28085711-2A7E55AA-294E-4FFB-9934-E4BF8AC7403B

Q28085711-2F20FDDA-9023-4F09-80C0-6E031341FA87

Q28085711-307EF4B6-CEB5-4C65-89A3-970C1EF4C81D

Q28085711-35718D5F-74D3-4468-9918-145CB1BB4571

P2888

Q28085711-8274E596-8DF4-4DBA-88A7-DF637CA23FC8

P304

Q28085711-E19E6F82-AD86-43A2-B6B9-82A1DE15FA56

P31

Q28085711-D814DCE8-2D3D-4546-B7C6-45D98E4AF4B8

P356

Q28085711-3BC70699-29A4-4724-94AD-70DBE854F802

P407

Q28085711-6BC62AEC-18CE-4532-9E84-3F3071421161

P433

Q28085711-88A7F541-583E-4DEB-BADF-F0371CADF90B

P478

Q28085711-5542C046-B387-49BF-8530-0EC640956B5C

P577

Q28085711-8AE53766-3170-42D7-B732-D9B6B1F479D9

P5875

Q28085711-0987E64D-E407-43F2-9267-8C56E305D006

P6179

Q28085711-A98BE43B-AA3D-427D-BF55-30054AA8D53E

P698

Q28085711-B295F6E8-BC8A-4538-980F-9601DA09563D

P921

Q28085711-A23FB4E5-7A20-4E5D-99A8-8CC7B651F25F

P932

Q28085711-2969ED90-583F-4557-A6F1-56E1745C3548

P356

S13193-014-0371-Y

P1433

Indian Journal of Surgical Oncology

P1476

Advances in chemotherapy for pancreatic cancer

@en

P2093

Ashish Singh

http://www.w3.org/2001/XMLSchema#string

Bhawna Sirohi

http://www.w3.org/2001/XMLSchema#string

Shaheenah Dawood

http://www.w3.org/2001/XMLSchema#string

Shailesh V. Shrikhande

http://www.w3.org/2001/XMLSchema#string

P2860

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.

Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.

A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin.

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.

Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.

P2888

s13193-014-0371-y

P304

47-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13193-014-0371-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271730218

http://www.w3.org/2001/XMLSchema#string

P6179

1019583348

http://www.w3.org/2001/XMLSchema#string

P698

25937764

http://www.w3.org/2001/XMLSchema#string

P921

P932

4412866

http://www.w3.org/2001/XMLSchema#string